Yüklüyor......
Rationale for STING-targeted cancer immunotherapy
The efficacy of checkpoint inhibitor therapy illustrates that cancer immunotherapy, which aims to foster the host immune response against cancer to achieve durable anticancer responses, can be successfully implemented in a routine clinical practice. However, a substantial proportion of patients does...
Kaydedildi:
| Yayımlandı: | Eur J Cancer |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362072/ https://ncbi.nlm.nih.gov/pubmed/28219022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.12.028 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|